In the absence of FcRn, the ability to eradicate tumors was impaired and there was no significant reduction in tumor cell numbers when mice were immunized with DEC205-targeted OVA, while only a mild reduction in tumor load occurred in response to Clec9A-targeted OVA (Fig. 2B). This evidence concerns the gene CLEC9A and neoplasm.